Skip to main content
. 2018 Oct 29;43(1):285–293. doi: 10.3892/ijmm.2018.3963

Figure 5.

Figure 5

Effects of chidamide and VPA on the expression levels of NF-κB pathway-associated proteins, p-IKKα/β, IKKα/β, NF-κB p65 and IκBα, in U266 and RPMI8226 cells, as determined by western blotting. (A) Effects of chidamide (2 µM) on the expression levels of NF-κB pathway-associated proteins in U266 cells. (B) Effects of chidamide (2 µM) on the expression levels of NF-κB pathway-associated proteins in RPMI8226 cells. (C) Effects of VPA (1 mM) on the expression levels of NF-κB pathway-associated proteins in U266 cells. (D) Effects of VPA (0.5 mM) on the expression levels of NF-κB pathway-associated proteins in RPMI8226 cells. IκBα, inhibitor of NF-κB; IKK, IκB kinase; NF-κB, nuclear factor-κB; p, phosphorylated; VPA, valproic acid.